Search

everythinglearnresearchcommunity

for

Search:↓

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Allopregnanolone changes gene expression in glioblastoma cells.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Removing alkaline phosphatase from human skin cells hinders the creation of new hair follicles.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A new gene, mrp4, is found in mice and may play a unique role in hair follicle development in tails and ears.

Atoh1 expression can create new Merkel cells in the skin.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Hair loss in androgenic alopecia patients is linked to changes in certain genes that control cell growth and death.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

Let-7b helps alpaca hair grow by reducing TGFβR I protein.

TRα and CRABPII genes change their activity levels during goat fetal skin development.

The G(S) alpha subunit gene may help start hair follicle growth in newborn mice.

Alopecia areata involves immune response and gene changes affecting hair loss.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

BST2 protein and certain T cells increase in early alopecia areata.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

Changing Allopregnanolone levels in newborns affects adult behavior and anxiety.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.